Basel Medical Group Ltd. has received a notification from Nasdaq stating that the company no longer meets the minimum bid price requirement of $1 per share, as its stock price remained below this threshold for 30 consecutive business days. The company has 180 calendar days to regain compliance, which could involve lifting its share price above $1 for at least ten consecutive business days or potentially implementing a reverse stock split. Failure to resolve the issue may result in delisting from Nasdaq, although an additional 180-day extension could be granted if certain conditions are met. Trading of the company's shares is not currently affected by this non-compliance.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Basel Medical Group Ltd. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 9631610) on January 23, 2026, and is solely responsible for the information contained therein.